1. Home
  2. LXEO vs RILY Comparison

LXEO vs RILY Comparison

Compare LXEO & RILY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXEO
  • RILY
  • Stock Information
  • Founded
  • LXEO 2017
  • RILY 1973
  • Country
  • LXEO United States
  • RILY United States
  • Employees
  • LXEO N/A
  • RILY N/A
  • Industry
  • LXEO
  • RILY Investment Managers
  • Sector
  • LXEO
  • RILY Finance
  • Exchange
  • LXEO Nasdaq
  • RILY Nasdaq
  • Market Cap
  • LXEO 140.6M
  • RILY 142.1M
  • IPO Year
  • LXEO 2023
  • RILY 2007
  • Fundamental
  • Price
  • LXEO $2.71
  • RILY $3.16
  • Analyst Decision
  • LXEO Strong Buy
  • RILY
  • Analyst Count
  • LXEO 5
  • RILY 0
  • Target Price
  • LXEO $22.20
  • RILY N/A
  • AVG Volume (30 Days)
  • LXEO 1.4M
  • RILY 858.4K
  • Earning Date
  • LXEO 05-08-2025
  • RILY 04-29-2025
  • Dividend Yield
  • LXEO N/A
  • RILY 17.86%
  • EPS Growth
  • LXEO N/A
  • RILY N/A
  • EPS
  • LXEO N/A
  • RILY N/A
  • Revenue
  • LXEO N/A
  • RILY $854,383,000.00
  • Revenue This Year
  • LXEO N/A
  • RILY N/A
  • Revenue Next Year
  • LXEO N/A
  • RILY N/A
  • P/E Ratio
  • LXEO N/A
  • RILY N/A
  • Revenue Growth
  • LXEO N/A
  • RILY N/A
  • 52 Week Low
  • LXEO $1.45
  • RILY $2.67
  • 52 Week High
  • LXEO $19.50
  • RILY $40.09
  • Technical
  • Relative Strength Index (RSI)
  • LXEO 48.48
  • RILY 39.62
  • Support Level
  • LXEO $1.90
  • RILY $2.74
  • Resistance Level
  • LXEO $2.64
  • RILY $3.44
  • Average True Range (ATR)
  • LXEO 0.48
  • RILY 0.34
  • MACD
  • LXEO 0.02
  • RILY -0.02
  • Stochastic Oscillator
  • LXEO 51.43
  • RILY 37.69

About LXEO Lexeo Therapeutics Inc.

Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.

About RILY B. Riley Financial Inc.

B. Riley Financial Inc is a diversified financial services company. The company through its subsidiaries offers investment banking and financial services to corporate, institutional, and high-net-worth clients and also asset disposition, valuation and appraisal, and capital advisory services to retail, wholesale, institutional, lenders, capital providers, private equity investors, and professional services firms in United States, Canada, and Europe. It also provides internet access and subscription services. The reportable operating segments of the company include Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications segment, and Consumer products segment.

Share on Social Networks: